Skip to Main Content

Paper Details

Safety and Efficacy of Istaroxime 1.0 and 1.5 µg/kg/min for Patients With Pre-Cardiogenic Shock.
J Card Fail
2
2023
Author NameAffiliation
Gerasimos FilippatosUniversity of Cyprus, School of Medicine & National and Kapodistrian University of Athens, Attikon University Hospital
Alexandre MebazaaUniversite Paris Cite Inserm UMR-S
  • 1 - 2

Datasets

Release 1.2